155 related articles for article (PubMed ID: 10810467)
1. Review of cellular mechanisms of tumor osteolysis.
Clohisy DR; Perkins SL; Ramnaraine ML
Clin Orthop Relat Res; 2000 Apr; (373):104-14. PubMed ID: 10810467
[TBL] [Abstract][Full Text] [Related]
2. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis.
Clohisy DR; Palkert D; Ramnaraine ML; Pekurovsky I; Oursler MJ
J Orthop Res; 1996 May; 14(3):396-402. PubMed ID: 8676252
[TBL] [Abstract][Full Text] [Related]
3. Tumor osteolysis in osteopetrotic mice.
Clohisy DR; Ogilvie CM; Ramnaraine ML
J Orthop Res; 1995 Nov; 13(6):892-7. PubMed ID: 8544026
[TBL] [Abstract][Full Text] [Related]
4. Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts.
Clohisy DR; Ogilvie CM; Carpenter RJ; Ramnaraine ML
J Orthop Res; 1996 Jan; 14(1):2-6. PubMed ID: 8618161
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
7. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
[TBL] [Abstract][Full Text] [Related]
8. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
9. Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
Nemoto R; Satou S; Mochizuki T; Okabe K
Cancer; 1992 May; 69(9):2316-21. PubMed ID: 1562978
[TBL] [Abstract][Full Text] [Related]
10. Osteoclasts are required for bone tumors to grow and destroy bone.
Clohisy DR; Ramnaraine ML
J Orthop Res; 1998 Nov; 16(6):660-6. PubMed ID: 9877389
[TBL] [Abstract][Full Text] [Related]
11. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
[TBL] [Abstract][Full Text] [Related]
12. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Quinn JM; McGee JO; Athanasou NA
J Pathol; 1998 Jan; 184(1):31-6. PubMed ID: 9582524
[TBL] [Abstract][Full Text] [Related]
13. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
14. Cellular and hormonal mechanisms associated with malignant bone resorption.
Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
[TBL] [Abstract][Full Text] [Related]
15. SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.
Murray LJ; Abrams TJ; Long KR; Ngai TJ; Olson LM; Hong W; Keast PK; Brassard JA; O'Farrell AM; Cherrington JM; Pryer NK
Clin Exp Metastasis; 2003; 20(8):757-66. PubMed ID: 14713109
[TBL] [Abstract][Full Text] [Related]
16. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
[TBL] [Abstract][Full Text] [Related]
17. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
18. Local bone resorption induced by serially transplantable human renal cell carcinoma in nude mice.
Nemoto R; Kanoh S; Koiso K; Shigenori S; Kabashima T; Haebara H
Urol Int; 1987; 42(5):326-9. PubMed ID: 3433578
[TBL] [Abstract][Full Text] [Related]
19. Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis.
Winding B; Misander H; Sveigaard C; Therkildsen B; Jakobsen M; Overgaard T; Oursler MJ; Foged NT
J Cancer Res Clin Oncol; 2000 Nov; 126(11):631-40. PubMed ID: 11079727
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
